Durable Hematological and Major Cytogenetic Response in a Patient with Isolated 20q Deletion Myelodysplastic Syndrome Treated with Lenalidomide

Myelodysplastic syndrome (MDS) is a clonal bone marrow disorder characterized by ineffective hematopoiesis. It is characterized by peripheral blood cytopenia and significant risk of progression to acute myeloid leukemia result. Deletion of the long arm of chromosome 20 (20q deletion) is present in 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Jana, Bagi, Khanfar, Anas, Ninan, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970358/
https://www.ncbi.nlm.nih.gov/pubmed/24716056
http://dx.doi.org/10.1155/2014/949515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970358/
https://www.ncbi.nlm.nih.gov/pubmed/24716056
http://dx.doi.org/10.1155/2014/949515

Ejemplares similares